Form 4 for ASMB ASSEMBLY BIOSCIENCES, INC.
Accepted 2023-03-31 00:00:00 ET · period of report 2023-03-29 · accession 0001209191-23-021868 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-31 | 2023-03-30 | ASMB | Okazaki Jason A | CEO, Pres, Dir | S - Sale | $0.82 | -4,247 | 98.2K | -4% | -$3,483 |
| D | 2023-03-31 | 2023-03-29 | ASMB | Okazaki Jason A | CEO, Pres, Dir | A - Grant | $0.00 | +470.0K | 470.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-30 | S | D | 4,247 | $0.82 | 98,174 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7795 to $0.89, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within. |
| 2 | Derivative | Stock Option (right to buy) | 2023-03-29 | A | A | 470,000 | $0.00 | 470,000 | D | $0.89 · — to 2033-03-29 | 470,000 Common Stock | (F3) Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2024; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2027. |